This article explores pacemaker and ICD system architecture, with a focus on connector types and interconnect technologies.
The Marx generator is a high-voltage tower from the 70s that sits in a forest near Moscow. It's the world's most powerful ...
The company shared new real-world findings for Aveir DR at the Asia Pacific Heart Rhythm Society (APHRS). These add to strong ...
Doctors at Madras Medical Mission Hospital in Chennai have successfully implanted leadless dual-chamber pacemakers in two ...
Researchers at UC San Francisco have developed a new way to improve walking for patients with Parkinson's disease using deep ...
LivaNova (Nasdaq: LIVN) today announced its new strategic roadmap and long-range financial plan at its 2025 Investor Day.
VisCardia will soon be enrolling almost 300 patients in a clinical trial.
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today hosted its 2025 Investor Day and presented its comprehensive strategic roadmap and long-range financial plan.
TipRanks on MSN
LivaNova expects OSA business to be break-even by 2029
The company has established a pathway to achieve this growth by maximizing its core businesses, scaling Obstructive Sleep Apnea, and preserving ...
A pivotal market shift towards user-centric devices is underway. Technological competition in portability and on-site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback